a) Change of risk calculation method
The fund will change its risk calculation method from Value at Risk (VaR) to the commitment approach. We decided to make this change because we regard the commitment method to be better suited to calculating the fund's global exposure.
b) Financial year
SEB Concept Biotechnology’s financial year will start 1 January and end 31 December each year. Previously, the financial year was 1 November to 31 October. To avoid confusion resulting from multiple reports during the transition period, the audit period is extended from the 1 November 2016 to 31 December 2017.
Updated product documentation, including SEB Concept Biotechnology’s prospectus dated October 2017, will be available on www.sebgroup.lu and can also be requested from our registered office.